According to the latest report by IMARC Group, titled “United States Transfection Technologies Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026,” the united states transfection technologies market is expected to exhibit moderate growth during 2021-2026.
Transfection technology refers to the method of artificially introducing various nucleic acids, such as oligonucleotides, Deoxyribonucleic Acid (DNA), and Ribonucleic Acid (RNA), into the eukaryotic cells. It can be done using biological, physical, and chemical methods, which aid in modifying specific properties of the cell. Transfection includes electroporation, cationic lipid transfection, in-vivo transfection, etc. At present, it is extensively used for numerous genomic studies, including gene expression, RNA interference, screening, etc.
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
United States Transfection Technologies Market Trends:
The elevating number of cases of infectious diseases that require antibiotics is driving the transfection technologies market in the United States. Additionally, the rising utilization of cell-based products is also augmenting the demand for transfection methods to treat various chronic diseases, such as tuberculosis, cardiovascular diseases, cancer, etc. Moreover, several reagent-based transfection technologies, including laserfection, biolistic technology, and microinjection, are gaining traction based on their accuracy and cost-effectiveness. Besides this, numerous manufacturers are focusing on extensive R&D activities for advanced cytological studies, cancer therapeutics, and precision medicine, which are also fueling the market growth in the country. Apart from this, increasing investments by both private and government bodies to develop large-scale transfection facilities are further anticipated to bolster the United States market over the forecasted period.
Request Free Sample Report: https://www.imarcgroup.com/united-states-transfection-technologies-market/requestsample
United States Transfection Technologies Market 2021-2026 Analysis and Segmentation:
The report has segmented the market on the basis on region, product type, application, transfection method, technology, end user.
Breakup by Product Type:
- Reagent
- Instrument
- Others
Breakup by Application:
- Therapeutic Delivery
- Bio-Medical Research
- Protein Production
- Others
Breakup by Transfection Method:
- Lipofection
- Eletroporation
- Nucleofection
- Cotransfection
- Cationic Lipid Transfection
- In-Vivo Transfection
- Others
Breakup by Technology:
- Physical Transfection
- Biochemical Based Transfection
- Viral-Vector Based Transfection
Breakup by End User:
- Research Centers and Academic Institutes
- Hospitals and Clinics
- Pharmaceutical and Biotechnology Companies
- Others
Breakup by Region:
- Northeast
- Midwest
- South
- West
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/united-states-transfection-technologies-market
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
Transfection represents the process of introducing foreign nucleic acids, including oligonucleotides, Deoxyribonucleic Acid (DNA), Ribonucleic Acid (RNA), etc., into the eukaryotic cells via nonviral procedures.
As a result, transfection technologies find extensive usage in target validation, drug discovery, cellular research, etc.Request for a PDF sample of this report: https://www.imarcgroup.com/europe-transfection-technologies-market/requestsampleThe increasing prevalence of several chronic diseases, such as cancer and cardiovascular ailments, is primarily strengthening the Europe transfection technologies market.
Besides this, the elevating focus on developing protein therapeutics, along with the rising collaborations among leading research institutes for drug discovery projects, is also acting as another significant growth-inducing factor.
Additionally, both pharmaceutical and biotech companies are increasingly investing in (R) activities, thereby bolstering the market growth in the region.
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Looking forward, IMARC Group expects the global market to continue its robust growth during the forecast period (2021-2026).Market Segmentation:Breakup by Product Type:ReagentInstrumentOthersBreakup by Application:Therapeutic DeliveryBio-Medical ResearchProtein ProductionOthersBreakup by Transfection Method:LipofectionEletroporationNucleofectionCotransfectionCationic Lipid TransfectionIn-Vivo TransfectionOthersBreakup by Technology:Physical TransfectionBiochemical Based TransfectionViral-Vector Based TransfectionBreakup by End User:Research Centers and Academic InstitutesHospitals and ClinicsPharmaceutical and Biotechnology CompaniesOthersBreakup by Country:GermanyFranceUnited KingdomItalySpainOthersAsk Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/europe-transfection-technologies-marketWe are updating our reports, If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc.
Mar 03, 2020: Global Transfection Technologies market is expected to grow at a significant CAGR in the upcoming period as the scope and its applications are rising enormously across the globe.
It helps to regulate gene therapy, protein metabolism, and mutation of cancer cells by affecting the nuclear genes.The factors that are playing a major role in the growth of transfection technologies market are the rise in research and development sector, the rising investment by private manufacturers and by the government, and the growing occurrence of cancer.
However, the high cost of instruments may restrain the overall market growth in the years to come.
Market of Transfection technologies is segmented based on type, application, and region.The siRNA delivery, gene delivery, protein delivery, and DNA delivery are the types that could be explored in transfection technologies market in the forecast period.
The market may be categorized based on applications like protein production, therapeutic delivery, biomedical research, and others that could be explored in the forecast period.To Request A Sample Copy Of This Report @: https://www.radiantinsights.com/research/global-transfection-technologies-market/request-sampleTransfection technologies market is segmented geographically into Americas (North America, South America), Europe (Eastern Europe, Western Europe), Asia Pacific (India, China, Japan, New Zealand, and Australia), Middle East (UAE, Saudi, and Qatar) and Africa (South Africa).
The reason behind the overall market growth could the growing occurrence of infectious diseases, the rising use of cell-based products, and the high demand for antibiotics.
